Syntheses and evaluation of glucosyl aryl thiosemicarbazide and glucosyl thiosemicarbazone derivatives as antioxidant and anti-dyslipidemic agents

被引:58
|
作者
Ghosh, Samir [1 ,2 ]
Misra, Anup Kumar [1 ,2 ]
Bhatia, Gitika [3 ]
Khan, M. M. [3 ]
Khanna, A. K. [3 ]
机构
[1] Bose Inst, Div Mol Med, Kolkata 700054, India
[2] Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
[3] Cent Drug Res Inst, Div Biochem, Lucknow 226001, Uttar Pradesh, India
关键词
Thiosemicarbazide; Thiosemicarbazone; Antidyslipidemic; Antioxidant; Cholesterol; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS; PATHOGENESIS; CHOLESTEROL; RADICALS; HDL;
D O I
10.1016/j.bmcl.2008.11.070
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-per-O-acetyl-glucosyl arylthiosemicarbazide and thiosemicarbazone derivatives have been synthesized and evaluated for their in vivo anti-dyslipidemic and in vitro antioxidant activities. Among 16 compounds tested, 3 compounds showed potent anti-dyslipidemic activity and 6 compounds showed potent antioxidant and scavenger of oxygen free radicals activity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:386 / 389
页数:4
相关论文
共 22 条
  • [21] Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents
    Bandgar, Babasaheb P.
    Adsul, Laxman K.
    Chavan, Hemant V.
    Jalde, Shivkumar S.
    Shringare, Sadanand N.
    Shaikh, Rafique
    Meshram, Rohan J.
    Gacche, Rajesh N.
    Masand, Vijay
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (18) : 5839 - 5844
  • [22] Synthesis, biological evaluation, molecular docking, MD simulation and DFT analysis of new 3-hydroxypyridine-4-one derivatives as anti-tyrosinase and antioxidant agents
    Sadeghian, Sara
    Zare, Fateme
    Khoshneviszadeh, Mehdi
    Hafshejani, Arian Fathi
    Salahshour, Farhang
    Khodabakhshloo, Ahmadreza
    Saghaie, Lotfollah
    Goshtasbi, Ghazal
    Sarikhani, Zahra
    Poustforoosh, Alireza
    Sabet, Razieh
    Sadeghpour, Hossein
    HELIYON, 2024, 10 (15)